Medan Pharmaceuticals

Bengaluru, India Founded: 2013 • Age: 13 yrs
Produces high-quality finished pharmaceutical formulations.

About Medan Pharmaceuticals

Medan Pharmaceuticals was a Healthcare company based in Bengaluru (India) founded in 2013. It produces high-quality finished pharmaceutical formulations. It operates on a B2B model. The company has 15 employees. Its Indian entity Medan Pharmaceuticals Private Limited reported revenue of β‚Ή1.72 Cr. The company is recorded as dissolved. Its focus areas include Pharmaceuticals, Manufacturing and Formulations. Similar companies include Akums, Jubilant Life Sciences and Nectar Lifesciences; 2 of its 3 listed similar companies have raised funding.

Company details

Medan Pharmaceuticals, based in Bengaluru, focuses on providing healthcare solutions, producing pharmaceutical products, producing manufactured goods, and formulations. Produces high-quality finished pharmaceutical formulations. The company prioritizes operational excellence, innovation, and customer-centric approaches for success. It continues to evolve, meeting industry challenges with strategic approaches.

Key Metrics
  • Annual Revenue
    ₹1.72 Cr

    FY 2025 · -7% YoY

  • Net Profit
    ₹9.7 Lakh

    FY 2025 · 6% margin

  • EBITDA
    ₹14.8 Lakh

    FY 2025 · 9% margin

  • Employee Count
    15

Board of directors of Medan Pharmaceuticals Private Limited (Medan Pharmaceuticals)

Medan Pharmaceuticals Private Limited is the primary company behind Medan Pharmaceuticals. The board of Medan Pharmaceuticals Private Limited currently have 4 directors; the longest-serving is Deepa Pattuvanmar Veetil, appointed in 2013. 2 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Deepa Pattuvanmar Veetil
DIN 06728454
Managing Director18 Nov 201312 yrs 11 moMedan Pharmaceuticals Private Limited
Kalla Veedu Nidhin
DIN 09280643
Director26 Oct 20224 yrsMedan Pharmaceuticals Private Limited
Vipin Pattuvanmar Veedu
DIN 09775062
Director26 Oct 20224 yrsMedan Pharmaceuticals Private Limited
Arjun Thekadavan
DIN 09775049
Director26 Oct 20224 yrsMedan Pharmaceuticals Private Limited

Financials of Medan Pharmaceuticals

Figures of Medan Pharmaceuticals Private Limited, the primary company behind Medan Pharmaceuticals, for FY 2025. Revenue was ₹1.72 Cr (-7% year on year). Net profit was ₹9.7 Lakh (6% margin). EBITDA was ₹14.8 Lakh (9% margin). Revenue has grown at a compounded annual rate of +1% over three years and +5% over five years.

  • ₹1.72 CrRevenue · FY 2025 · -7% YoY
  • ₹9.7 LakhNet profit · 6% margin
  • ₹14.8 LakhEBITDA · 9% margin
  • ₹31 LakhPaid-up capital
  • 15Employees (provident fund records)
  • +1%Revenue CAGR, 3 years
  • +5%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Medan Pharmaceuticals Private Limited are on its company page.

Premium access

Detailed financial statements for Medan Pharmaceuticals

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Similar companies to Medan Pharmaceuticals

Medan Pharmaceuticals has 3 listed similar companies in our database, 2 of them funded. They include Akums, Jubilant Life Sciences and Nectar Lifesciences.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
akums.in2004Delhi, India$70M395
CDMO focusing on spectrum of dosage forms and therapeutic segments
jubl.com1978Noida, India
Company offering a suite of R&D and manufacturing services for small molecules and generics
neclife.com1995Chandigarh, India$46.85M175
Cephalosporin APIs and generic formulations are manufactured.
Premium access

Detailed similar companies of Medan Pharmaceuticals

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Medan Pharmaceuticals

Medan Pharmaceuticals was founded in 2013.

Medan Pharmaceuticals is headquartered in Bengaluru, India. It is registered at Bengaluru, Karnataka, India.

Medan Pharmaceuticals has 15 employees.

The primary company behind Medan Pharmaceuticals, Medan Pharmaceuticals Private Limited, reported revenue of β‚Ή1.72 Cr for FY 2025, down 7% year on year.

Medan Pharmaceuticals, based in Bengaluru, focuses on providing healthcare solutions, producing pharmaceutical products, producing manufactured goods, and formulations. Produces high-quality finished pharmaceutical formulations. The company prioritizes operational excellence, innovation, and customer-centric approaches for success. It continues to evolve, meeting industry challenges with strategic approaches.

Medan Pharmaceuticals's top competitors include Jubilant Life Sciences, Akums and Nectar Lifesciences.

Medan Pharmaceuticals operates through Medan Pharmaceuticals Private Limited.

The legal entities of Medan Pharmaceuticals currently have 4 directors, including Kalla Veedu Nidhin, Deepa Pattuvanmar Veetil, Vipin Pattuvanmar Veedu and others.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available